Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 1251–1300 of 33040
the Senior Vice President, General Counsel and Corporate Secretary of Cracker Barrel Old Country Store, Inc. (the “Company”), Richard Wolfson, notified the Company of his intent to retire on May 5, 2026
On April 27, 2026, Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, informed Acadia Pharmaceuticals Inc. (the “Company”) of her planned retirement.
Dr. Lin will succeed Lucinda Warren whose resignation as Interim President and Chief Executive Officer was effective as of April 30, 2026
Thomas M. “Roe” Patterson and C. Richard Vermillion ceased serving as directors of the Company
C. Richard Vermillion ceased serving as directors of the Company
Andrew Gundlach was appointed Executive Chairman of the Board and resigned as President and Chief Executive Officer of the Company, effective April 29, 2026
the engagement of Jeffrey T. Varsalone as Chief Restructuring Officer of the Company and its subsidiaries was terminated, effective immediately.
Mr. Carhart’s departure was not as a result of any dispute with the Company.
Effective as of May 1, 2026 (the “Effective Date”), PodcastOne, Inc. (the “Company”) appointed Craig Christensen as the Company’s Interim Chief Financial Officer, Interim Treasurer and Interim Secretary, to succeed Ryan Carhart, the former Chief Financial Officer, Treasurer and Secretary of the Company, who notified the Company on April 28, 2026 that he is leaving the Company to pursue another professional opportunity effective as of the Effective Date.
Following receipt of formal notice on April 27, 2026, Dustin Plantholt departed from his role as Chief AI & Marketing Officer of Health In Tech, Inc. (the “Company”), effective as of April 30, 2026, as part of a business transition and not as a result of any disagreement with the Company on any matter relating to its operations, policies or practices.
The Company and Mr. Yi Lu, the Company’s Chief Executive Officer, director and Chairman of the Board, have mutually agreed that a leadership transition is necessary and in the best interests of the Company.
Effective as of May 8, 2026, Christi Powitzky resigned as the Chief Compliance Officer of Teucrium Trading, LLC (the “Sponsor”), Sponsor of Teucrium Agricultural Fund, Teucrium Wheat Fund, Teucrium Soybean Fund, Teucrium Sugar Fund, Teucrium Corn Fund, and 7RCC Spot Bitcoin and Carbon Credit Futures ETF (collectively, the “Funds”), each a series of the Teucrium Commodity Trust (the “Registrant”).
Michael E. Fortin has given his notice of resignation as the Chief Financial Officer of the Company effective May 15, 2026.
On April 30, 2026, Michael Johnston informed Worksport Ltd., a Nevada corporation (the “Company”), of his resignation as the Company’s Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.
Jeremy “Deke” Williamson ceased serving as the Chief Operating Officer and Jay Voncannon ceased serving as Chief Financial Officer of Arq, Inc.
Jeremy “Deke” Williamson ceased serving as the Chief Operating Officer and Jay Voncannon ceased serving as Chief Financial Officer of Arq, Inc.
On April 30, 2026, Atish Shah notified the Company of his decision to not stand for reelection to the Board at the Company's 2026 annual meeting of shareholders, to be held on June 18, 2026 (the "Annual Meeting").
On April 27, 2026, Sheen Khoury was terminated as the Executive Vice President, Worldwide Sales and Marketing of A10 Networks, Inc., effective immediately.
On April 27, 2026, Robert Lipstein notified the Onfolio Holdings Inc. (the “Company”) Chair of the Board that he intended to resign as a director of the Company effective May 31, 2026.
On April 30, 2026, Eben Tessari informed Kiniksa Pharmaceuticals International, plc (the "Company") of his decision to resign as Chief Strategy Officer of the Company to pursue another executive position within the life sciences industry.
Nikul Patel, Skillz Inc.’s (the “Company”) Interim General Counsel, departed from the Company on April 28, 2026.
John Bissell has stepped down as Chief Executive Officer, effective May 1, 2026.
Bilge Ogut resigned from the Board, including any committees thereof, effective immediately.
Mark A. Gramz informed The Marcus Corporation (the “Company”) of his intent to retire as the President of Marcus Theatres, effective as of March 31, 2026. Subsequently, on April 7, 2026, the Company announced that Mr. Gramz would instead retire on May 1, 2026 (the “Retirement Date”).
On April 30, 2026, Teleflex Incorporated (the “Company”) announced the appointment of Jason Weidman as the Company’s President and Chief Executive Officer, effective as of June 8, 2026 (the “Start Date”), replacing interim President and Chief Executive Officer Stuart A. Randle at that time.
On April 28, 2026, Scott C. Selbach retired from Carlisle Companies Incorporated (the “Company”) as Executive Vice President, Government Relations & Secretary after more than 35 years of valuable service to the Company.
Kevin S. Cavanah, Vice President of Finance and Chief Financial Officer, and Nancy E. Austin, Chief Administrative Officer, will step down from their respective positions on the terms substantially as described below.
Ms. Austin will step down as Vice President and Chief Administrative Officer of the Company effective as of May 7, 2026.
Pamela S. Seymon as a member of the Board, which is also effective as of the 2026 Annual Meeting.
On April 26, 2026, the consulting agreement between the Company and Hungerford Consulting LLC, under which Brian Hungerford had served as Chief Financial Officer, terminated at the request of Hungerford Consulting LLC.
Christopher Meyer’s service as the Company’s interim principal financial officer and principal accounting officer will conclude on May 31, 2026, in connection with the expiration of his independent contractor agreement with the Company, dated November 28, 2025, and the appointment of Mr. Graff as the Company’s principal financial officer and principal accounting officer on such date.
In addition, on April 29, 2026, Kurt Azarbarzin, Vince Burgess and Federica O’Brien (the “ Resigning Directors ”) each tendered his or her resignation from the Board...
In addition, on April 29, 2026, Kurt Azarbarzin, Vince Burgess and Federica O’Brien (the “ Resigning Directors ”) each tendered his or her resignation from the Board...
In addition, on April 29, 2026, Kurt Azarbarzin, Vince Burgess and Federica O’Brien (the “ Resigning Directors ”) each tendered his or her resignation from the Board...
On April 29, 2026, Doug Evans, Chairman of the Board of Directors (the “ Board ”) of the Company, notified the Company and the Board that he will not stand for re-election at the Company’s 2026 Annual Meeting of Stockholders (the “ 2026 Annual Meeting ”) and will retire from the Board...
On April 27, 2026, Christopher Winkle notified the Company of his resignation from the Board, effective May 31, 2026.
Also on the Effective Date, Dr. Sullivan resigned from the Board of Directors of the Company.
On April 29, 2026 (the “Effective Date”), the Separation Agreement between the Company and Dr. Sullivan became binding and effective, addressing Dr. Sullivan’s separation from the Company.
On April 27, 2026, Brian Herb, Executive Vice President, Chief Financial and Administrative Officer of CCC Intelligent Solutions Holdings Inc. (the “Company”), notified the Company that he will resign from his role with the Company effective May 25, 2026, to accept another opportunity.
Mr. Sabol will replace Mr. Mark Weaver, who was serving as Interim Chief Financial Officer until the Company hire a permanent Chief Financial Officer.
On April 30, 2026, ResMed Inc. (the “Company”) announced that Brett Sandercock, Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, will retire from his role as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer.
and Diego Scotti will cease to serve as the EVP, General Manager, Consumer Group of the Company
On April 29, 2026, PayPal Holdings, Inc. (the " Company ") announced that, effective as of June 2, 2026, Michelle Gill will cease to serve as the EVP, General Manager, Small Business and Financial Services of the Company
On April 24, 2026, Ronald McClurg notified NeuroOne Medical Technologies Corporation (the "Company") of his intention to retire as the Company’s Chief Financial Officer.
As a result of his termination for Cause, Mr. Neugebauer was automatically removed from the Company’s board of directors.
On April 30, 2026, the Company terminated Mr. Toby Neugebauer’s employment for Cause pursuant to his Employment Agreement as a result of conduct in violation of the terms of such agreement and of Company policies.
On April 27, 2026, William F. Greene notified Moving iMage Technologies, Inc. (the “Company”) of his retirement and resignation from his position as Chief Financial Officer of the Company effective April 27, 2026.
Mr. Blackman succeeds Mr. Drapczuk as the Company’s principal financial officer and principal accounting officer.
On April 28, 2026, Christopher Gibson, Ph.D., Chair of the Board of Directors (the “Board”) of Recursion Pharmaceuticals, Inc. (the “Company”) and a member of the Research and Development Committee, Technology Committee, and the Corporate Social Responsibility Committee of the Board, informed the Company that he will not stand for re-election to the Board as a Class II Director at the 2026 Annual Meeting of Stockholders (the “2026 Annual Meeting”).
On April 30, 2026, Thomas G. Zernick retired as Chief Executive Officer, principal executive officer, and a director of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.